BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, June 11, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

July 7, 2011

View Archived Issues

Bardoxolone methyl improves renal function in BEAM trial in diabetes-associated kidney disease

Read More

Protein epitope mimetic POL-7085 alleviates symptoms of allergic asthma in vivo

Read More

Novel antibacterial agents disclosed by Basilea Pharmaceutica

Read More

Titan Pharmaceuticals to begin unblinding and data analysis for confirmatory Probuphine trial

Read More

Pfizer's phase III Lyrica trial in fibromyalgia meets primary endpoint

Read More

BTG acquires U.S. commercial rights to Wellstat Therapeutics' candidate for overexposure to 5-FU

Read More

Detailed phase III data on ipilimumab/dacarbazine in metastatic melanoma

Read More

GSK presents new selective lysophospholipid S1P1 receptor agonist with promise to treat arthritis

Read More

Exemestane prevents breast cancer in at-risk postmenopausal women in NCIC CTG MAP.3 trial

Read More

Full pivotal trial data reported on vemurafenib in V600E-mutated B-raf melanoma

Read More

New triterpenes for HCV infection patented by Meiji Seika

Read More

Actelion synthesizes new formylpeptide receptor modulators

Read More

Shionogi & Co. presents novel beta-secretase 1 inhibitors

Read More

Relin and MingSight join to develop MS-553 for diabetes-related eye disease

Read More

Novartis claims new acetyl-CoA carboxylase 2 inhibitors

Read More

Luminex acquires EraGen Biosciences

Read More

Novel PI3K inhibitors patented by GSK

Read More

Jubilant Discovery Services and Janssen Pharmaceutica enter into drug discovery alliance

Read More

Advanced Cell Technology's RPE cells gain E.U. orphan drug status in Stargardt's macular dystrophy

Read More

Amgen submits sBLA to expand Xgeva indication to reduce risk of bone metastasis in prostate cancer

Read More

NCCN to support phase I trial of Threshold Pharmaceuticals' TH-302 with pazopanib in solid tumors

Read More

First-in-human trial of ANAVEX 2-73 for Alzheimer's disease advances

Read More

Gentium submits NDA to FDA for defibrotide in treatment of hepatic veno-occlusive disease

Read More

Preclinical data show antifibrotic effect of AZX-100 in lung tissue

Read More

Pharmasset and Tibotec Pharmaceuticals agree to conduct phase II study of PSI-7977 and TMC-435

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 11, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 9, 2026
  • 3D rendering of β2-Adrenergic receptor GPCR protein molecule embedded in lipid bilayer membrane.

    Skape Bio unlocks GPCR targets with de novo-designed miniproteins

    BioWorld
    Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
  • Wuxi Apptec signage

    Wuxi Apptec insists it’s ‘not a Chinese military company’

    BioWorld
    Wuxi Apptec isn’t going down without a fight after the U.S. Department of Defense added it to the Section 1260H list June 8 as a designated “Chinese military...
  • Hands holding paper

    Researchers hit back after colleagues removed from ADA meeting

    BioWorld
    Former principal officers of the American Diabetes Association (ADA) have hit back at the association’s board and CEO after it prohibited the distribution of an...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing